69 related articles for article (PubMed ID: 14716795)
1. Interleukin 7 induces the growth of breast cancer cells through a wortmannin-sensitive pathway.
Al-Rawi MA; Rmali K; Mansel RE; Jiang WG
Br J Surg; 2004 Jan; 91(1):61-8. PubMed ID: 14716795
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 7 upregulates vascular endothelial growth factor D in breast cancer cells and induces lymphangiogenesis in vivo.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Br J Surg; 2005 Mar; 92(3):305-10. PubMed ID: 15672426
[TBL] [Abstract][Full Text] [Related]
3. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
Lin Y; Wang SM; Huang RP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
[TBL] [Abstract][Full Text] [Related]
4. The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells.
Al-Rawi MA; Watkins G; Mansel RE; Jiang WG
Int J Oncol; 2005 Sep; 27(3):721-30. PubMed ID: 16077922
[TBL] [Abstract][Full Text] [Related]
5. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
6. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
7. Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer.
Singh B; Berry JA; Vincent LE; Lucci A
J Surg Res; 2006 Jul; 134(1):44-51. PubMed ID: 16678856
[TBL] [Abstract][Full Text] [Related]
8. [Effects of adenoviral-mediated melanoma differentiation associated gene-7/IL-24 on growth and apoptosis of breast cancer cells].
Ni QC; Yang L; Zhang CH; Zhou F; Zhu HJ; Huang JF
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):3008-11. PubMed ID: 19080082
[TBL] [Abstract][Full Text] [Related]
9. Role of interleukin-8 in the progression of estrogen receptor-negative breast cancer.
Yao C; Lin Y; Ye CS; Bi J; Zhu YF; Wang SM
Chin Med J (Engl); 2007 Oct; 120(20):1766-72. PubMed ID: 18028768
[TBL] [Abstract][Full Text] [Related]
10. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Xu X; Wang B; Ye C; Yao C; Lin Y; Huang X; Zhang Y; Wang S
Cancer Lett; 2008 Mar; 261(2):147-57. PubMed ID: 18171602
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
Hu M; Wang J; Chen P; Reilly RM
Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
[TBL] [Abstract][Full Text] [Related]
14. Different signalling pathways regulate VEGF and IL-8 expression in breast cancer: implications for therapy.
Chelouche-Lev D; Miller CP; Tellez C; Ruiz M; Bar-Eli M; Price JE
Eur J Cancer; 2004 Nov; 40(16):2509-18. PubMed ID: 15519527
[TBL] [Abstract][Full Text] [Related]
15. Involvement of PPARalpha in the growth inhibitory effect of arachidonic acid on breast cancer cells.
Bocca C; Bozzo F; Martinasso G; Canuto RA; Miglietta A
Br J Nutr; 2008 Oct; 100(4):739-50. PubMed ID: 18304389
[TBL] [Abstract][Full Text] [Related]
16. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
17. COX-2 induces IL-11 production in human breast cancer cells.
Singh B; Berry JA; Shoher A; Lucci A
J Surg Res; 2006 Apr; 131(2):267-75. PubMed ID: 16457848
[TBL] [Abstract][Full Text] [Related]
18. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010
[TBL] [Abstract][Full Text] [Related]
20. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
